Literature DB >> 21737960

The concept of metabolic syndrome: contribution of visceral fat accumulation and its molecular mechanism.

Yuji Matsuzawa1, Tohru Funahashi, Tadashi Nakamura.   

Abstract

Although abdominal obesity or visceral obesity is considered to be one of the components of metabolic syndrome and to have an important role in a cluster of cardiovascular risks, there is no consensus about the definition and diagnostic criteria for this syndrome, probably because there is considerable disagreement about the location and definition of abdominal obesity or visceral obesity.In this review article, the important role of visceral fat accumulation in the development of a variety of lifestyle-related diseases is shown, including cardiovascular disease based on our clinical studies using CT scans, and the mechanism of these disorders is discussed, focusing on adipocytokines, especially adiponectin.The importance of diagnosing metabolic syndrome, in which visceral fat accumulation plays an essential role in the development of multiple risk factors, should be emphasized because lifestyle modification for the reduction of visceral fat may be very effective for the reduction of risks of this type, namely metabolic syndrome in the narrow sense.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21737960     DOI: 10.5551/jat.7922

Source DB:  PubMed          Journal:  J Atheroscler Thromb        ISSN: 1340-3478            Impact factor:   4.928


  117 in total

1.  Effect of metabolic syndrome components and their clustering on carotid atherosclerosis in a sample of the general Japanese population.

Authors:  Chiaki Hirata; Nobuyuki Miyai; Ayaka Idoue; Miyoko Utsumi; Sonomi Hattori; Akihiko Iwahara; Yuji Uematsu; Mitsuru Shiba; Mikio Arita
Journal:  Hypertens Res       Date:  2016-01-21       Impact factor: 3.872

2.  Intermuscular and intramuscular adipose tissues: Bad vs. good adipose tissues.

Authors:  Gary J Hausman; Urmila Basu; Min Du; Melinda Fernyhough-Culver; Michael V Dodson
Journal:  Adipocyte       Date:  2014-12-10       Impact factor: 4.534

Review 3.  Metabolic syndrome: pathophysiology, management, and modulation by natural compounds.

Authors:  Yogita Rochlani; Naga Venkata Pothineni; Swathi Kovelamudi; Jawahar L Mehta
Journal:  Ther Adv Cardiovasc Dis       Date:  2017-06-22

Review 4.  Metabolic syndrome and lifestyle modification.

Authors:  Mitsuyoshi Takahara; Iichiro Shimomura
Journal:  Rev Endocr Metab Disord       Date:  2014-12       Impact factor: 6.514

Review 5.  Does the brain shrink as the waist expands?

Authors:  Auriel A Willette; Dimitrios Kapogiannis
Journal:  Ageing Res Rev       Date:  2014-04-22       Impact factor: 10.895

6.  Effect of High-Intensity Interval Training on Plasma Omentin-1 Concentration in Overweight/Obese and Normal-Weight Youth.

Authors:  Nejmeddine Ouerghi; Mohamed Kacem Ben Fradj; Ikram Bezrati; Moncef Feki; Naziha Kaabachi; Anissa Bouassida
Journal:  Obes Facts       Date:  2017-08-05       Impact factor: 3.942

7.  Time Course of Blood Pressure Decrease After Bariatric Surgery in Normotensive and Hypertensive Patients.

Authors:  Devon N Hawkins; Byron J Faler; Yong U Choi; Balakrishna M Prasad
Journal:  Obes Surg       Date:  2018-07       Impact factor: 4.129

8.  Lumbar epidural lipomatosis is associated with visceral fat and metabolic disorders.

Authors:  Shingo Morishita; Yoshiyasu Arai; Toshitaka Yoshii; Kenichiro Sakai; Takashi Hirai; Atsushi Okawa
Journal:  Eur Spine J       Date:  2018-05-02       Impact factor: 3.134

Review 9.  Sirtuins-Mediated System-Level Regulation of Mammalian Tissues at the Interface between Metabolism and Cell Cycle: A Systematic Review.

Authors:  Parcival Maissan; Eva J Mooij; Matteo Barberis
Journal:  Biology (Basel)       Date:  2021-03-04

10.  Leisure-time exercise, physical activity during work and commuting, and risk of metabolic syndrome.

Authors:  Keisuke Kuwahara; Toru Honda; Tohru Nakagawa; Shuichiro Yamamoto; Shamima Akter; Takeshi Hayashi; Tetsuya Mizoue
Journal:  Endocrine       Date:  2016-03-07       Impact factor: 3.633

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.